News
Latest developments at Biocell
Covid-19: Auckland firm develops RNA production platform, paving way for Kiwi vaccine
Stuff, Auckland, NZ, 06 Nov 2021
A Papatoetoe company has developed the ability to mass-produce a crucial ingredient in cutting edge pharmaceuticals, setting the stage for homegrown Covid-19 vaccines. Biotechnology firm BioCell has devised a way to produce ribonucleic acid (RNA) on an industrial scale never before seen in New Zealand. RNAs are molecules similar to DNA, crucial for the flow of genetic information […]
NZ-first vaccine filling machine nears completion, could boost vaccine supply
RNZ, Auckland, NZ, 13 August 2021
An Auckland-based biotechnology company says its New Zealand-first vaccine filling machine is on target for completion in Germany, and will potentially boost Covid-19 vaccine supply not only in New Zealand but globally […]
Government allocates $3M to Biocell as part of the Covid-19 vaccine strategy.
Beehive.govt.nz, Wellington, NZ, 27 August 2020
Prime Minister Jacinda Ardern, and Research, Science and Innovation Minister Megan Wood have allocated $3 million to BioCell for the upgrade of our facilities, which will allow for large-scale[…]
Stabilitech takes next step in race for a vaccine, announces Biocell as manufacturer for OraPro-COVID-19
Burges Hill, UK, 12 June 2020
STABILITECH BIOPHARMA LTD (“Stabilitech”), a UK biotechnology company developing next generation vaccines and biopharmaceuticals, has announced today a partnership with BioCell […]
Free Radical Scientist Awarded 2011 Rutherford Medal
Stuff, Auckland, NZ, 17 November 2011
The 2011 Rutherford Medal, New Zealand’s top science and technology honour, was awarded to Professor Christine Winterbourn, director of the free radical research group in the pathology department at the University of Otago […]
